TD: Tardive Dyskinesia for total (+) active metabolites for tetrabenazine & deutetrabenazine Schneider et al (2021) Adapted from Diana (2007), Schneider et al (2021) & Cheung & Parmar (2022) References: Aminoff MJ (2024): Pharmacologic Management of Parkinsonism & Other Movement Disorders (Chapter 28)
For enthusiasts seeking variety, speed, and trustworthy gameplay, a modern gaming platform must balance presentation, fairness, and customer support
1 2 3 4 5 Clinical oral medicine and pathology
Many of the cardiovascular and metabolic trials informing the discussion were not designed to evaluate ophthalmic outcomes. The authors called for prospective ophthalmology-specific studies incorporating imaging biomarkers, visual outcomes and disease-specific monitoring, noting that parsing the protective benefits or adverse effects of this rapidly growing medication class will be essential to refining disease management and improve patient outcomes. As GLP-1 therapies become increasingly common among patients with diabetes, obesity and vascular comorbiditiesprecisely the populations populating ophthalmic clinicsthe field may not have the luxury of waiting for cleaner data
it is an autoimmune condition that can affect confidence, emotional well-being, and daily life